Harvard scientists will try to clone embryos for stem cells

MALCOLM RITTER
Tue Jun 6, 7:04 PM ET

(AP) - Stepping into a research area marked by controversy and fraud, Harvard University scientists said Tuesday they are trying to clone human embryos to create stem cells they hope can be used one day to help conquer a host of diseases.

"We are convinced that work with embryonic stem cells holds enormous promise," said Harvard provost ...

The UK MS Society is selling tracksuits. Is it just me, but I wouldn't be seen dead in a tracksuit advertising that I had MS. Also, given that mobility problems etc are common - when would one wear such a costume? At the tennis club, playing football etc?

http://www.mssociety.org.uk/get_involve ... suits.html

Given the re-approval of Tysabri, it's not surprising that the CRAB manufacturers are looking for other ways to boost their sales.

Ian

Schering says MS drug Betaferon approved in EU for early-stage treatment

Schering AG said its multiple sclerosis drug Betaferon has been approved in Europe as a first-line treatment for the earliest stages of multiple sclerosis.

The approval is valid in all 25 European member states as well as in Iceland and Norway. ...

Japanese Scientists Create Brain Cells from Stem Cells

--------------------------------------------------------------------------------

Japanese scientists create brain cells from stem cells
Posted February 11, 2005 in ALS Research
Copyright 2005 Jiji Press Ltd.
Jiji Press Ticker Service
February 10, 2005, Thursday
LENGTH: 672 words
DATELINE: Tokyo, Feb. 10

Using a newly developed cell culture method, mouse ES cells, pluripotent cells that can develop into various tissues and organs, were differentiated into nerve cells at a success rate of 90 ...

From the NMSS website

http://www.nationalmssociety.org/tysabri_qanda.asp

You read this sort of research and you have to conclude that the MS researchers have got years of well-paid work ahead of them.

http://www.msif.org/go.rm?id=14250

US OKs resumed sales of Biogen and Elan's Tysabri


WASHINGTON (Reuters) - Biogen Idec Inc. and Elan Corp. won permission on Monday to resume sales of their multiple sclerosis drug Tysabri, which was withdrawn last year after it was linked to a rare but potentially fatal brain disease, U.S. regulators said.

The U.S. Food and Drug Administration said Tysabri must be sold under a restricted distribution plan to minimize chances of harm. Tysabri should be ...

US OKs resumed sales of Biogen and Elan's Tysabri


WASHINGTON (Reuters) - Biogen Idec Inc. and Elan Corp. won permission on Monday to resume sales of their multiple sclerosis drug Tysabri, which was withdrawn last year after it was linked to a rare but potentially fatal brain disease, U.S. regulators said.


The U.S. Food and Drug Administration said Tysabri must be sold under a restricted distribution plan to minimize chances of harm. Tysabri should be ...

John had one bout in 1998 of optic neuritis and then up to 2004 he had mini symptoms that no one ever connected to MS. His last main bout was Aug 2004 when he went lame and had pins and needles. That corrected in June of 2005. I'm knocking on wood as I write this :D but since 2004 we have really had nothing other than ...